CLC and type 1 diabetes mellitus: We believe our study can be an initial step toward unraveling the role of the eosinophils and galectin-10 in patients with T1D and we speculate that galectin-10-based treatment could be used to slow down or even hinder the destruction of insulin producing beta cells.